Bluebird Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Casdin CapitalEuropean Innovation Council FundEuropean Investment Bank+6 more
Kriya provides working capital loans and business finance products to UK and European businesses, helping them manage cash flow, fund wholesale orders, and scale their buyer base.
FintechSaaS
Anil Stocker(Founder)in
Co-investorsMouro CapitalNorthzoneForesite CapitalJDRF T1D FundNarya CapitalPatient Square Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.